1. Home
  2. SNDL vs DNA Comparison

SNDL vs DNA Comparison

Compare SNDL & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SNDL Inc.

SNDL

SNDL Inc.

HOLD

Current Price

$1.46

Market Cap

381.0M

Sector

Health Care

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$8.23

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNDL
DNA
Founded
2006
2008
Country
Canada
United States
Employees
N/A
485
Industry
Pharmaceuticals and Biotechnology
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
381.0M
455.8M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
SNDL
DNA
Price
$1.46
$8.23
Analyst Decision
Strong Buy
Hold
Analyst Count
1
2
Target Price
$5.00
$8.50
AVG Volume (30 Days)
1.6M
1.2M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.19
N/A
Revenue Next Year
$3.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$5.37
52 Week High
$2.89
$17.58

Technical Indicators

Market Signals
Indicator
SNDL
DNA
Relative Strength Index (RSI) 52.85 47.31
Support Level $1.45 $7.59
Resistance Level $1.50 $9.58
Average True Range (ATR) 0.05 0.76
MACD 0.00 -0.09
Stochastic Oscillator 69.23 30.18

Price Performance

Historical Comparison
SNDL
DNA

About SNDL SNDL Inc.

SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: